Developer docs
API playgroundTry for free, no card

Search company profiles

Wele Clinic

Full company profile

uuid00sp22o

Namestring
Wele Clinic
Legal namestring
Wele Clinic
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Wele Clinic is a privately held, single-location psychiatric practice operating from 1123 Broadway in Manhattan, New York City, founded in 2022 by board-certified adult psychiatrist Dr. Mehdi Omidvari. The clinic specializes in interventional psychiatry for treatment-resistant depression and related mood and anxiety disorders, offering four core services: IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, evidence-based psychotherapy, and pharmacological medication management. Patients are treated on-site under medical supervision with supports such as zero gravity chairs and advanced monitoring technology, and the clinic's clinical positioning targets adults who have failed to respond to at least two traditional antidepressant trials.

The underlying technology is pharmacological rather than software-based: ketamine and esketamine act on the brain's glutamate system and NMDA receptors to produce rapid-onset antidepressant effects measured in hours to days, compared with weeks for conventional SSRIs. The clinic cites outcome figures of up to 70% of treatment-resistant patients improving with ketamine therapy and approximately 64% improving within three months of Spravato treatment. Dr. Omidvari's clinical training spans Johns Hopkins (Interventional Psychiatry and TMS), SUNY Brooklyn, Mount Sinai (Psychosomatic Medicine fellowship), and NYU (psychodynamic psychotherapy), giving the practice a credentialed interventional focus.

Revenue is generated on a fee-for-service basis across all four modalities, with the clinic accepting major insurance plans including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare, alongside out-of-pocket payment. No pricing is publicly disclosed. The clinic is a direct-to-consumer, sales-led practice with no external investors, no parent organization, and no headcount disclosures; all named evidence (six testimonials, one founder profile) indicates a founder-operated private practice. The clinic markets itself through content marketing (educational blog articles on Spravato and ketamine) and organic SEO, and claims a service catchment spanning all five NYC boroughs plus Jersey City and Long Island.

Short descriptiontext

Wele Clinic is a Manhattan-based private psychiatric practice founded in 2022 by Dr. Mehdi Omidvari, specializing in IV ketamine therapy, Spravato (esketamine), psychotherapy, and medication management for treatment-resistant depression and complex mental health conditions across the NYC metropolitan area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWest New York, United States
HQ citystring
West New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychiatric services, ketamine therapy, Spravato treatment, treatment-resistant depression, medication management
Industry2 codes
PRIMARYHLAFACAA
Outpatient Mental Health Clinics & Counseling Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Psychiatric Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Psychiatric Treatment Services
TypeProfessional Services
Description

Fee-for-service medical services including ketamine therapy sessions, Spravato treatments, psychotherapy sessions, and medication management. Patients pay via insurance or out-of-pocket, with the clinic accepting major insurance providers including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare.

weleclinicnyc.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Wele Clinic provides outpatient psychiatric care specializing in interventional treatments for treatment-resistant depression, including IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, psychotherapy, and medication management. Patients begin with a comprehensive psychiatric evaluation and receive personalized treatment plans combining medication and therapy approaches.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 70% of patients with treatment-resistant depression experience significant improvement with ketamine therapy
+2 more records
Product overview1 text field

Wele Clinic is a mental health and psychiatric clinic offering a coordinated suite of treatments led by Dr. Mehdi Omidvari: Ketamine Therapy (IV infusions for treatment-resistant depression, PTSD, anxiety, OCD), Spravato Treatment (FDA-approved esketamine nasal spray for treatment-resistant depression), Psychotherapy (evidence-based talk therapy sessions), and Medication Management (pharmacological treatment planning and monitoring). The clinic specializes in innovative, rapid-acting treatments for patients who have not responded to traditional antidepressants, serving Manhattan and the greater New York City area.

Product and service4 records
1Ketamine Therapy
CategoryInterventional Psychiatry
Description

Innovative IV ketamine treatments for rapid mental health relief, targeting the brain's glutamate system to reset neural circuits affected by treatment-resistant depression, PTSD, anxiety, and OCD. Administered to individual patients at the Manhattan clinic by a board-certified psychiatrist.

2Spravato Treatment
CategoryInterventional Psychiatry
Description

FDA-approved esketamine nasal spray administered under clinical supervision for treatment-resistant depression and major depressive disorder with suicidal ideation. Targets NMDA receptors in the glutamate system for rapid-acting antidepressant effects, often covered by major insurance plans.

3Psychotherapy
CategoryBehavioral Health Services
Description

Evidence-based psychotherapy sessions addressing mood and anxiety disorders, ADHD, trauma-related issues, sleep issues, stress management, self-esteem, relationship concerns, and compulsions. Provided to individual patients in the NYC metropolitan area.

4Medication Management
CategoryPsychiatric Treatment
Description

Expert pharmacological medication management plans for depression and anxiety, including evaluation, prescription, initiation, monitoring, and ongoing review of psychiatric medications to ensure effectiveness and safety for individual patients.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Emblem Health is accepted as an insurance provider at Wele Clinic, allowing insured patients to access psychiatric services including ketamine therapy, Spravato treatment, psychotherapy, and medication management.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Outpatient behavioral health platform partnering with psychiatric practices. Potentially comparable as a strategic partner or roll-up acquirer of independent psychiatric clinics like Wele Clinic.

2Done.
TypeRegional player
Description

Telehealth ADHD and psychiatric care provider. Comparable in psychiatric services delivery but focused on stimulant medication management for ADHD rather than treatment-resistant depression or interventional psychiatry.

3Field Trip Health
TypeDirect peer
Description

Ketamine-assisted psychotherapy clinic chain (now operating as Stella) offering psychedelic-assisted mental health treatments. Comparable to Wele Clinic in ketamine-based treatment model and treatment-resistant patient focus.

4Nue Life
TypeEmerging player
Description

Ketamine therapy platform combining in-clinic infusions with digital mental health support. Comparable in ketamine treatment offering and treatment-resistant patient focus, though with a hybrid digital model.

TypeBroad incumbent
Description

Tech-enabled psychiatric practice group operating across multiple states with in-network insurance coverage. Comparable to Wele Clinic in psychiatric services and insurance-accepting model, though broader in scope and lacking interventional psychiatry specialization.

TypeOthers
Description

Employer-sponsored mental health benefit platform that connects employees to in-network therapists and psychiatrists. Comparable as a referral ecosystem participant that channels patients to clinics like Wele Clinic.

TypeDirect peer
Description

Multi-state interventional psychiatry provider offering IV ketamine, Spravato, and TMS for treatment-resistant depression and anxiety. Directly comparable to Wele Clinic in modality mix, patient segment, and physician-led clinical model.

TypeOthers
Description

Employer mental health benefits provider with a network of therapy and psychiatry providers. Comparable as a referral channel that could direct patients to in-network interventional psychiatry clinics like Wele Clinic.

TypeBroad incumbent
Description

Large-scale telehealth mental health provider offering medication management and therapy. Comparable to Wele Clinic in medication management and psychiatric services, though Cerebral operates primarily via telehealth rather than in-person interventional care.

TypeEmerging player
Description

At-home ketamine therapy provider serving patients across multiple U.S. states. Comparable as a competitor for ketamine treatment-seeking patients, though operating through a remote/guided model rather than in-clinic.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wele Clinic

Psychiatric Servicesweleclinicnyc.com

Wele Clinic is a Manhattan-based private psychiatric practice founded in 2022 by Dr. Mehdi Omidvari, specializing in IV ketamine therapy, Spravato (esketamine), psychotherapy, and medication management for treatment-resistant depression and complex mental health conditions across the NYC metropolitan area.

What Wele Clinic does

Wele Clinic is a privately held, single-location psychiatric practice operating from 1123 Broadway in Manhattan, New York City, founded in 2022 by board-certified adult psychiatrist Dr. Mehdi Omidvari. The clinic specializes in interventional psychiatry for treatment-resistant depression and related mood and anxiety disorders, offering four core services: IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, evidence-based psychotherapy, and pharmacological medication management. Patients are treated on-site under medical supervision with supports such as zero gravity chairs and advanced monitoring technology, and the clinic's clinical positioning targets adults who have failed to respond to at least two traditional antidepressant trials.

The underlying technology is pharmacological rather than software-based: ketamine and esketamine act on the brain's glutamate system and NMDA receptors to produce rapid-onset antidepressant effects measured in hours to days, compared with weeks for conventional SSRIs. The clinic cites outcome figures of up to 70% of treatment-resistant patients improving with ketamine therapy and approximately 64% improving within three months of Spravato treatment. Dr. Omidvari's clinical training spans Johns Hopkins (Interventional Psychiatry and TMS), SUNY Brooklyn, Mount Sinai (Psychosomatic Medicine fellowship), and NYU (psychodynamic psychotherapy), giving the practice a credentialed interventional focus.

Revenue is generated on a fee-for-service basis across all four modalities, with the clinic accepting major insurance plans including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare, alongside out-of-pocket payment. No pricing is publicly disclosed. The clinic is a direct-to-consumer, sales-led practice with no external investors, no parent organization, and no headcount disclosures; all named evidence (six testimonials, one founder profile) indicates a founder-operated private practice. The clinic markets itself through content marketing (educational blog articles on Spravato and ketamine) and organic SEO, and claims a service catchment spanning all five NYC boroughs plus Jersey City and Long Island.

Wele Clinic firmographics

Firmographics
Name
Wele Clinic
Legal name
Wele Clinic
Website
https://weleclinicnyc.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Wele Clinic is a Manhattan-based private psychiatric practice founded in 2022 by Dr. Mehdi Omidvari, specializing in IV ketamine therapy, Spravato (esketamine), psychotherapy, and medication management for treatment-resistant depression and complex mental health conditions across the NYC metropolitan area.
Ownership category
akta.pro rank

Wele Clinic industry classification

Industry
Product category
Psychiatric Services
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFACAA
Outpatient Mental Health Clinics & Counseling Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Psychiatric services
  • Ketamine therapy
  • Spravato treatment
  • Treatment-resistant depression
  • Medication management

Where Wele Clinic is headquartered

Location

Headquarters

HQ city
West New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Wele Clinic business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Psychiatric Treatment Services: Fee-for-service medical services including ketamine therapy sessions, Spravato treatments, psychotherapy sessions, and medication management. Patients pay via insurance or out-of-pocket, with the clinic accepting major insurance providers including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Wele Clinic product offering

Product offering

Core offering

Wele Clinic provides outpatient psychiatric care specializing in interventional treatments for treatment-resistant depression, including IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, psychotherapy, and medication management. Patients begin with a comprehensive psychiatric evaluation and receive personalized treatment plans combining medication and therapy approaches.

Product overview

Wele Clinic is a mental health and psychiatric clinic offering a coordinated suite of treatments led by Dr. Mehdi Omidvari: Ketamine Therapy (IV infusions for treatment-resistant depression, PTSD, anxiety, OCD), Spravato Treatment (FDA-approved esketamine nasal spray for treatment-resistant depression), Psychotherapy (evidence-based talk therapy sessions), and Medication Management (pharmacological treatment planning and monitoring). The clinic specializes in innovative, rapid-acting treatments for patients who have not responded to traditional antidepressants, serving Manhattan and the greater New York City area.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ketamine Therapy Innovative IV ketamine treatments for rapid mental health relief, targeting the brain's glutamate system to reset neural circuits affected by treatment-resistant depression, PTSD, anxiety, and OCD. Administered to individual patients at the Manhattan clinic by a board-certified psychiatrist.
  • Spravato Treatment FDA-approved esketamine nasal spray administered under clinical supervision for treatment-resistant depression and major depressive disorder with suicidal ideation. Targets NMDA receptors in the glutamate system for rapid-acting antidepressant effects, often covered by major insurance plans.
  • Psychotherapy Evidence-based psychotherapy sessions addressing mood and anxiety disorders, ADHD, trauma-related issues, sleep issues, stress management, self-esteem, relationship concerns, and compulsions. Provided to individual patients in the NYC metropolitan area.
  • Medication Management Expert pharmacological medication management plans for depression and anxiety, including evaluation, prescription, initiation, monitoring, and ongoing review of psychiatric medications to ensure effectiveness and safety for individual patients.

Quantifiable outcome

  • Up to 70% of patients with treatment-resistant depression experience significant improvement with ketamine therapy
  • +2 more outcomes

Companies that use Wele Clinic

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Wele Clinic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Wele Clinic partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Emblem HealthminorOthersEmblem Health is accepted as an insurance provider at Wele Clinic, allowing insured patients to access psychiatric services including ketamine therapy, Spravato treatment, psychotherapy, and medication management.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Wele Clinic competitors and assessment

Company assessment

Others

  • ARC Health: Outpatient behavioral health platform partnering with psychiatric practices. Potentially comparable as a strategic partner or roll-up acquirer of independent psychiatric clinics like Wele Clinic.
  • Lyra Health: Employer-sponsored mental health benefit platform that connects employees to in-network therapists and psychiatrists. Comparable as a referral ecosystem participant that channels patients to clinics like Wele Clinic.
  • Spring Health: Employer mental health benefits provider with a network of therapy and psychiatry providers. Comparable as a referral channel that could direct patients to in-network interventional psychiatry clinics like Wele Clinic.

Regional players

  • Done. Telehealth ADHD and psychiatric care provider. Comparable in psychiatric services delivery but focused on stimulant medication management for ADHD rather than treatment-resistant depression or interventional psychiatry.

Direct peers

  • Field Trip Health: Ketamine-assisted psychotherapy clinic chain (now operating as Stella) offering psychedelic-assisted mental health treatments. Comparable to Wele Clinic in ketamine-based treatment model and treatment-resistant patient focus.
  • Bespoke Treatment: Multi-state interventional psychiatry provider offering IV ketamine, Spravato, and TMS for treatment-resistant depression and anxiety. Directly comparable to Wele Clinic in modality mix, patient segment, and physician-led clinical model.

Emerging players

  • Nue Life: Ketamine therapy platform combining in-clinic infusions with digital mental health support. Comparable in ketamine treatment offering and treatment-resistant patient focus, though with a hybrid digital model.
  • Mindbloom: At-home ketamine therapy provider serving patients across multiple U.S. states. Comparable as a competitor for ketamine treatment-seeking patients, though operating through a remote/guided model rather than in-clinic.

Broad incumbents

  • Talkiatry: Tech-enabled psychiatric practice group operating across multiple states with in-network insurance coverage. Comparable to Wele Clinic in psychiatric services and insurance-accepting model, though broader in scope and lacking interventional psychiatry specialization.
  • Cerebral: Large-scale telehealth mental health provider offering medication management and therapy. Comparable to Wele Clinic in medication management and psychiatric services, though Cerebral operates primarily via telehealth rather than in-person interventional care.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Wele Clinic social profiles

Digital presence

Wele Clinic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wele Clinic leadership team

Management profile

Number of profiles

Profiles1 record

Wele Clinic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wele Clinic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wele Clinic

What does Wele Clinic do?

Wele Clinic provides outpatient psychiatric care specializing in interventional treatments for treatment-resistant depression, including IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, psychotherapy, and medication management. Patients begin with a comprehensive psychiatric evaluation and receive personalized treatment plans combining medication and therapy approaches.

Is Wele Clinic a public or private company?

Wele Clinic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Wele Clinic founded?

Wele Clinic was founded in 2022. It employs 1 to 10 people.

Where is Wele Clinic based?

Wele Clinic is headquartered in West New York, United States, in the North America region.

How does Wele Clinic make money?

One revenue line is on record: psychiatric Treatment Services.

Who are Wele Clinic's main competitors?

Others on record are ARC Health, Lyra Health and Spring Health. Done. is listed as a regional player. Direct peers are Field Trip Health and Bespoke Treatment. Emerging players are Nue Life and Mindbloom. Broad incumbents are Talkiatry and Cerebral.

Does Wele Clinic have an API?

No public API is recorded for Wele Clinic.

What industry is Wele Clinic in?

Wele Clinic's product category is Psychiatric Services. Its primary akta.pro industry code is HLAFACAA, Outpatient Mental Health Clinics & Counseling Centers, with a secondary code of HLAFABAC, Outpatient Mental Health & Counseling Clinics. Its NAICS code is 621112 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales